Neuropilin‐2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours
- 16 July 2002
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 198 (1) , 77-82
- https://doi.org/10.1002/path.1179
Abstract
Neuropilin‐2 (NP‐2) is a cell surface transmembrane protein originally characterized as a receptor for the type 3 semaphorins, and more recently for a number of vascular endothelial growth factor (VEGF) isoforms. NP‐2 expression has been recently localized to a subset of neuroendocrine cells in the gastrointestinal tract. The aim of this study was to define the expression pattern of NP‐2 in normal pancreatic islets and to determine the utility of NP‐2 expression as a diagnostic marker of pancreatic endocrine tumours. Paraffin‐embedded tissue sections from 30 endocrine pancreatic tumours (EPTs) and from normal pancreas were immunostained with a rabbit polyclonal antibody generated towards NP‐2. Nineteen of the tumours were hormonally functional (nine insulinomas, nine gastrinomas, and one glucagonoma). The NP‐2 staining pattern was correlated with islet cell hormone expression. In addition, NP‐2 expression was evaluated in other normal neuroendocrine tissues and neuroendocrine neoplasms. In normal pancreas, NP‐2 stained a distinct subset of islet cells situated primarily at the islet periphery. Double immunohistochemical staining revealed co‐localization with glucagon‐expressing cells. Moderate to strong NP‐2 staining was present in 27 of 30 EPTs. Serial staining of the pancreatic tumours with insulin, gastrin, glucagon, pancreatic polypeptide (PP) or somatostatin did not reveal a distinct pattern of co‐localization. NP‐2 expression was not detected in neuroendocrine cells outside the gastroenteropancreatic system, or in their corresponding neoplasms, except for focal staining in one bronchial carcinoid tumour. In conclusion, the vast majority of EPTs examined expressed NP‐2, suggesting its utility as a diagnostic marker for these tumours. The function of NP‐2 in islet cell biology or tumourigenesis remains to be elucidated. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Neuroendocrine Cells along the Digestive Tract Express Neuropilin-2Biochemical and Biophysical Research Communications, 2001
- Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progressionThe FASEB Journal, 2000
- VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissuesThe FASEB Journal, 2000
- Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGFJournal of Biological Chemistry, 2000
- Semaphorin SEMA3F Localization in Malignant Human Lung and Cell LinesThe American Journal of Pathology, 2000
- Neuroendocrine tumours of the pancreasBritish Journal of Surgery, 2000
- A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology.Journal of Histochemistry & Cytochemistry, 1996
- Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesisMolecular Endocrinology, 1995
- Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cellsJournal of Clinical Endocrinology & Metabolism, 1995
- A Diagnostic Clue and Potential PitfallThe American Journal of Surgical Pathology, 1995